Showing results (581-590 of 593) with videos related to
Sort By:
Pageof 60
Journal of Medicinal Chemistry|December 11, 2020
Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological MalignanciesBernard Barlaam, Robert Casella, Justin Cidado, et al.ACS Medicinal Chemistry Letters|November 21, 2017
Correction to "Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors"Jeffrey W Johannes, Stephanie Bates, Carl Beigie, et al.Nature Communications|December 19, 2018
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemiaAdriana E Tron, Matthew A Belmonte, Ammar Adam, et al.ACS Medicinal Chemistry Letters|February 16, 2017
Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 InhibitorsJeffrey W Johannes, Stephanie Bates, Carl Beigie, et al.Plos One|January 5, 2012
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspectiveCharles R Beck, Bruce C McKenzie, Ahmed B Hashim, et al.Influenza and Other Respiratory Viruses|September 17, 2013
Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysisCharles R Beck, Bruce C McKenzie, Ahmed B Hashim, et al.Annals of Internal Medicine|March 3, 2025
Molecular Imaging Versus Adrenal Vein Sampling for the Detection of Surgically Curable Primary Aldosteronism : A Prospective Within-Patient TrialEmily Goodchild, Xilin Wu, Russell Senanayake, et al.The Journal of Trauma|January 12, 2007
Practice patterns and outcomes of retrievable vena cava filters in trauma patients: an AAST multicenter studyRiyad Karmy-Jones, Gregory J Jurkovich, George C Velmahos, et al.The Lancet. Diabetes & Endocrinology|February 26, 2021
Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settingsDianna J Magliano, Lei Chen, Rakibul M Islam, et al.Journal of Medicinal Chemistry|September 3, 2025
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human KinomeAvipsa Ghosh, Afshan Ahmed, Konstantina Amoiradaki, et al.Pageof 60